Quest Partners LLC Amicus Therapeutics, Inc. Transaction History
Quest Partners LLC
- $920 Billion
- Q1 2025
A detailed history of Quest Partners LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 37,411 shares of FOLD stock, worth $234,192. This represents 0.03% of its overall portfolio holdings.
Number of Shares
37,411
Previous 10,732
248.59%
Holding current value
$234,192
Previous $101 Million
201.97%
% of portfolio
0.03%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding FOLD
# of Institutions
315Shares Held
319MCall Options Held
378KPut Options Held
575K-
Wellington Management Group LLP Boston, MA29.2MShares$183 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.1MShares$182 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$153 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY21.5MShares$134 Million7.33% of portfolio
-
Avoro Capital Advisors LLC New York, NY20.5MShares$128 Million2.71% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $1.76B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...